Our project leader Dr Meryl Roudaut was invited to present at the last ISVHLD congress, the Global Hepatitis Summit, in Taiwan. The theme of the summit, “Evolution and Revolution of Viral Hepatitis and Liver Disease”, was perfect to talk about the use of BIOMIMESYS® product to overcome the limitations of 2D liver models. Méryl talked about his PhD work, dealing with the differentiation of human iPSCs into liver organoids, and their characterization by RNAseq and pharmacological tests, and how this unpreceded 3D liver model can be a useful tool for drug screening.

We would like to deeply thank the organizers of the event for their support, Professor Pei-Jer Chen (president) and Professor Jia-Horng Kao (Scientific Program Chair)

We also want to thank Professor Cheng-Yuan Peng for the perfect organization of the session.

We are available for any question you might have about this project, Méryl’s results and BIOMIMESYS! Please feel free to contact us at hello@biomimesys.com

Grégory MAUBON

Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created www.augmented-reality.fr and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.


Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.